GBCIX
Price
$18.13
Change
+$0.17 (+0.95%)
Updated
Jun 26 closing price
Net Assets
19.15M
RMEBX
Price
$58.60
Change
+$0.43 (+0.74%)
Updated
Jun 26 closing price
Net Assets
106.24B
Interact to see
Advertisement

GBCIX vs RMEBX

Header iconGBCIX vs RMEBX Comparison
Open Charts GBCIX vs RMEBXBanner chart's image
Gabelli Dividend Growth I
Price$18.13
Change+$0.17 (+0.95%)
VolumeN/A
Net Assets19.15M
American Funds American Mutual R2E
Price$58.60
Change+$0.43 (+0.74%)
VolumeN/A
Net Assets106.24B
GBCIX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GBCIX vs. RMEBX commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBCIX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 106B vs. GBCIX (19.2M). RMEBX pays higher dividends than GBCIX: RMEBX (1.16) vs GBCIX (0.60). GBCIX was incepted earlier than RMEBX: GBCIX (21 years) vs RMEBX (11 years). GBCIX (2.40) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 31.00 vs. GBCIX (23.00). RMEBX has a lower initial minimum investment than GBCIX: RMEBX (250) vs GBCIX (10000). RMEBX annual gain was more profitable for investors over the last year : 9.50 vs. GBCIX (-0.51). RMEBX return over 5 years is better than : 62.71 vs. GBCIX (34.39).
GBCIXRMEBXGBCIX / RMEBX
Total Expense Ratio1.001.0793%
Annual Report Gross Expense Ratio2.401.07224%
Fund Existence21 years11 years-
Gain YTD6.0217.31582%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets19.2M106B0%
Annual Yield % from dividends0.601.1651%
Returns for 1 year-0.519.50-5%
Returns for 3 years14.9325.8858%
Returns for 5 years34.3962.7155%
Returns for 10 years4.7074.516%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VIR5.310.12
+2.31%
Vir Biotechnology
SPRO2.90N/A
N/A
Spero Therapeutics
AMED98.03-0.05
-0.05%
Amedisys
SHG44.16-0.24
-0.54%
Shinhan Financial Group Co Ltd
DFDV17.94-0.92
-4.88%
DeFi Development Corp